vida: research 2026 04 28 #4602

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 08:52:32 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 08:53 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 08:53 UTC*
Member
  1. Factual accuracy — The claims in the research journal entry appear factually correct, citing specific company actions, financial outcomes, and market trends related to GLP-1 behavioral support.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the content in the research journal is unique, and the inbox files are distinct archive metadata.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes (WeightWatchers bankruptcy vs. Omada's IPO) to support the "atoms-to-bits" thesis.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file to check for brokenness.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, citing specific company actions, financial outcomes, and market trends related to GLP-1 behavioral support. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the content in the research journal is unique, and the inbox files are distinct archive metadata. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes (WeightWatchers bankruptcy vs. Omada's IPO) to support the "atoms-to-bits" thesis. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file to check for brokenness. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/), or sources in inbox/queue/ — none are claims or entities requiring frontmatter validation, so schema compliance is not applicable to this PR's content type.

2. Duplicate/redundancy:
This is a research journal entry documenting a new investigation session (2026-04-28) with distinct focus on GLP-1 behavioral support market stratification; it references previous sessions (25-30) but presents new empirical evidence (WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration) not present in prior entries, so no redundancy detected.

3. Confidence:
No claims are being modified or created in this PR — this is purely a research journal entry documenting an investigation process and confidence shifts in existing beliefs, so confidence calibration review is not applicable.

4. Wiki links:
The journal entry references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims; no wiki link syntax is used, so no broken links detected.

5. Source quality:
The journal entry cites nine new sources in inbox/queue/ covering WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration, PHTI employer coverage data, and manufacturer DTE channels — these appear to be substantive primary sources appropriate for the commercial market analysis being conducted.

6. Specificity:
Not applicable — this PR contains research journal documentation and source files, not claim files that require falsifiability assessment.

Additional observations:
The research journal entry demonstrates rigorous methodology (explicit disconfirmation attempts, natural experiment identification, cross-domain pattern validation) and documents a significant empirical finding (WeightWatchers bankruptcy vs. Omada profitability as atoms-to-bits validation); the meta-commentary on belief refinement vs. refutation shows appropriate epistemic humility.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/), or sources in inbox/queue/ — none are claims or entities requiring frontmatter validation, so schema compliance is not applicable to this PR's content type. **2. Duplicate/redundancy:** This is a research journal entry documenting a new investigation session (2026-04-28) with distinct focus on GLP-1 behavioral support market stratification; it references previous sessions (25-30) but presents new empirical evidence (WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration) not present in prior entries, so no redundancy detected. **3. Confidence:** No claims are being modified or created in this PR — this is purely a research journal entry documenting an investigation process and confidence shifts in existing beliefs, so confidence calibration review is not applicable. **4. Wiki links:** The journal entry references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims; no [[wiki link]] syntax is used, so no broken links detected. **5. Source quality:** The journal entry cites nine new sources in inbox/queue/ covering WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration, PHTI employer coverage data, and manufacturer DTE channels — these appear to be substantive primary sources appropriate for the commercial market analysis being conducted. **6. Specificity:** Not applicable — this PR contains research journal documentation and source files, not claim files that require falsifiability assessment. **Additional observations:** The research journal entry demonstrates rigorous methodology (explicit disconfirmation attempts, natural experiment identification, cross-domain pattern validation) and documents a significant empirical finding (WeightWatchers bankruptcy vs. Omada profitability as atoms-to-bits validation); the meta-commentary on belief refinement vs. refutation shows appropriate epistemic humility. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 08:54:05 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 08:54:05 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 08:56:21 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.